Home » Valeant extends offer to acquire Allergan
Valeant extends offer to acquire Allergan
August 20, 2014
Valeant Pharmaceuticals International has extended the expiration of its exchange offer to acquire all outstanding shares of Allergan to 5:00 p.m., New York City time, Dec. 31. The exchange offer previously was scheduled to expire at 5:00 p.m., New York City time, Friday, Aug. 15. All other terms and conditions of the exchange offer remain unchanged.
The depositary of the exchange offer has advised that, as of 9:00 a.m., New York City time, on Aug. 15, a total of approximately 12,509,606 shares of Allergan common stock were validly tendered and not properly withdrawn in the exchange offer.